Clinical trials: Pancreatic Enzyme Abnormality
Pancreatic Insufficiency, Pancreatic Cancer
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Does pancreas enzyme replacement (PERT) decrease weight loss and improve quality of life in patients with unresectable pancreatic cancer?
- Conditions
- Pancreatic Insufficiency, Pancreatic Cancer, Pancreatic Enzyme Abnormality
- Trial name
- NCT02985801
- Testing
- Pancrelipase
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- Massimo Raimondo, M.D.